S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial

PURPOSE: We conducted a randomized, multicenter, phase III trial to compare S-1 plus docetaxel (DS) with S-1 plus cisplatin (SP) as adjuvant chemotherapy for stage III gastric cancer patients. MATERIALS AND METHODS: Stage III gastric cancer patients who had received curative gastrectomy with D2 lymp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Choong-kun, Jung, Minkyu, Kim, Hyo Song, Jung, Inkyung, Shin, Dong Bok, Kang, Seok Yun, Zang, Dae Young, Kim, Ki Hyang, Lee, Moon Hee, Kim, Bong-Seog, Lee, Kyung Hee, Cheong, Jae-Ho, Hyung, Woo Jin, Noh, Sung Hoon, Chung, Hyun Cheol, Rha, Sun Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333977/
https://www.ncbi.nlm.nih.gov/pubmed/29397659
http://dx.doi.org/10.4143/crt.2018.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333977/
https://www.ncbi.nlm.nih.gov/pubmed/29397659
http://dx.doi.org/10.4143/crt.2018.028

Ejemplares similares